AIRLINK 202.36 Increased By ▲ 1.12 (0.56%)
BOP 10.16 Increased By ▲ 0.19 (1.91%)
CNERGY 7.17 Increased By ▲ 0.28 (4.06%)
FCCL 37.15 Increased By ▲ 1.79 (5.06%)
FFL 17.16 Increased By ▲ 0.01 (0.06%)
FLYNG 25.73 Increased By ▲ 1.52 (6.28%)
HUBC 135.40 Decreased By ▼ -2.79 (-2.02%)
HUMNL 14.11 Increased By ▲ 0.04 (0.28%)
KEL 4.85 Decreased By ▼ -0.01 (-0.21%)
KOSM 6.69 Increased By ▲ 0.03 (0.45%)
MLCF 46.30 Decreased By ▼ -0.01 (-0.02%)
OGDC 222.57 Increased By ▲ 0.03 (0.01%)
PACE 7.02 Decreased By ▼ -0.04 (-0.57%)
PAEL 42.51 Decreased By ▼ -0.63 (-1.46%)
PIAHCLA 17.05 Increased By ▲ 0.02 (0.12%)
PIBTL 8.60 Increased By ▲ 0.06 (0.7%)
POWER 9.67 Increased By ▲ 0.57 (6.26%)
PPL 188.25 Decreased By ▼ -0.51 (-0.27%)
PRL 42.45 Decreased By ▼ -0.82 (-1.9%)
PTC 25.30 Decreased By ▼ -0.05 (-0.2%)
SEARL 108.20 Decreased By ▼ -2.22 (-2.01%)
SILK 1.02 Decreased By ▼ -0.01 (-0.97%)
SSGC 42.50 Decreased By ▼ -0.14 (-0.33%)
SYM 18.44 Decreased By ▼ -0.13 (-0.7%)
TELE 9.09 Decreased By ▼ -0.03 (-0.33%)
TPLP 13.50 Decreased By ▼ -0.18 (-1.32%)
TRG 67.89 Decreased By ▼ -0.27 (-0.4%)
WAVESAPP 10.35 Increased By ▲ 0.08 (0.78%)
WTL 1.85 Decreased By ▼ -0.02 (-1.07%)
YOUW 4.04 Increased By ▲ 0.03 (0.75%)
BR100 12,257 Increased By 37 (0.3%)
BR30 37,254 Decreased By -63.3 (-0.17%)
KSE100 116,056 Increased By 211 (0.18%)
KSE30 36,565 Increased By 88.6 (0.24%)

KARACHI: The Pakistan Chemists and Druggists Association (PCDA) strongly condemned the imposition of an 18% general sales tax (GST) on alternative medicines and demanded immediate withdrawal. The tax hike is expected to increase prices by 20-25%, making these medicines unaffordable for the middle class.

A delegation from PCDA, led by Ghulam Hashim Noorani and Abdul Samad Budhani, met with Fayyaz Magon, Senior Vice President of the Federation of Pakistan Chambers of Commerce and Industry (FPCCI), to express their concerns. They urged the PCDA to play a role in getting the GST revoked.

The delegation explained that alternative medicines, including herbal and homeopathic remedies, are used by the middle class and are not subsidized by the government. The GST imposition will not only increase prices but also harm importers, traders, and retailers, potentially disrupting the distribution system and leading to a nationwide shortage of medicines.

The PCDA demanded that the government either provide subsidies and concessions to the pharmaceutical sector or exempt alternative medicines from GST, additional taxes, and withholding tax for non-filers. They called for immediate amendments to the Finance Bill and the issuance of an SRO to exempt medicines regulated under the DRAP Act and Medical Device Act from taxes.

The association warned that if the taxes are not withdrawn, it will lead to a significant increase in prices, making medicines unaffordable for the common man, and ultimately harming the public health.

Copyright Business Recorder, 2024

Comments

Comments are closed.